BMS-790052 dihydrochloride;Daclatasvir dihydrochloride;BMS790052 HCl

• Post Date:

  Jan 23,2013

• Expiry Date:

  Jan 23,2014

• Detailed Description:

  Cas No. :1009119-65-6 Quantity: 1Kilograms
  

  BMS-790052 is a first-in-class, highly-selective oral HCV NS5A inhibitor. NS5A is an essential component for hepatitis C virus (HCV) replication complex. BMS-790052 has broad genotype coverage and exhibits picomolar in vitro potency against genotypes 1a (EC50 50pm) and 1b (EC50 9pm). BMS-790052 produces a robust decline in HCV RNA (-3.6 logs after 48 hours from a single 100 mg) dosefollowing a single dose in patients chronically infected with HCV genotype 1.
  http://www.chemscene.com/BMS-790052-dihydrochloride.html

• CAS Registry Number:

  1009119-65-6

• Synonyms:

  ;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;Daclatasvir dihydrochloride;Daclatasvir.2HCL;

• Molecular Structure:

  

• Company:

  ChemScene, LLC     [ United States ]        

• Contact:

  Dr. Gao

• Tel:

  732-484-9848

• Fax:

  888-484-5008

• Email:

  information@chemscene.com